Growing prevalence of chronic disease is projected to accelerate the market growth of the peripherally inserted central catheters
Peripherally inserted, or PICC as it is
also known, catheters are usually used for long-lasting, one-time access to a
specific body part. The catheter can be a very valuable tool in medical care
especially for those patients who have had their circulatory systems
compromised by surgery or an accident. The use of a catheter introduced via a
vein makes this procedure much more comfortable for the patient because the
catheter is placed in an area that is out of the way and hidden from view.
Patients who undergo short-term access to a specific body part via the use of a
PICC are far less likely to develop complications than those who use typical
long-acting peripheral venous access devices. These devices can cause several
complications if not used properly because they are made of thin, hollow
needles. This creates an entry point for bacteria that can lead to infection
and also cause nausea and diarrhea.
Increasing expenditure on the healthcare
industry coupled with the rise in the prevalence of chronic disease is
projected to drive market growth. The growing geriatric population is
increasing prevalence of the various chronic disease is again fueling the
market growth of the peripherally
inserted central catheters. According to the World Health Organization, by 2050,
the world's population aged 60 years and older is expected to total 2 billion,
up from 900 million in 2015. Also, increasing advancement in the catheters
device is again anticipated to foster the market growth of the peripherally
inserted central catheters over the forecast period.
North America is expected to gain
significant growth over the forecast period and this is attributed to
increasing healthcare expenditure by the regional government coupled with the
continuous launch of the new and advanced product. For instance, in March 2020,
Access Vascular Inc. received FDA clearance for the second generation of its
HydroPICC peripherally inserted central catheter (PICC), which has demonstrated
a thrombus accumulation rate 30 times less than traditional PICCs1 and which
may provide the potential to reduce catheter occlusions.
Key
Developments:
1.
In
July 2018, 3M Korea announced that it has launched a new centralized catheter
anchoring system that reduces the risk of bloodstream infection, called the
“PICC/CVC securement device+CHG Dressing” package system.
2.
In
December 2017, B. Braun Medical Inc. recently introduced the Introcan Safety®
Deep Access IV Catheters to its growing portfolio of products that help improve
the success of peripheral intravenous PIV access.
Comments
Post a Comment